WHO ICTRP trial
A phase I/II study for peptide vaccine of vascular endothelial growth factor…
JPRN-UMIN000013381 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000013381 |
|---|---|
| Public title | A phase I/II study for peptide vaccine of vascular endothelial growth factor receptor-1/2 in patients with primary malignant glioma |
| Scientific title | A phase I/II study for peptide vaccine of vascular endothelial growth factor receptor-1/2 in patients with primary malignant glioma - VEGFR1/2 peptide vaccine for patients with primary malignant glioma |
| Primary sponsor | Department of Neurosurgery, Keio University School of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase I,II |
| Countries | Japan |
| Conditions | Malignant glioma |
| Interventions | Subcutaneous injection of VEGFR1 and VEGFR2 peptides (2mg, respectively) with IFA. Weekly administration, 8 times and then monthly administration, 6 times; total 14 times. |
| Registration date | Oct 3, 2014 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: